Cite
MLA Citation
I. Vaxman et al.. “P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE.” HemaSphere, vol. 6, n.d., pp. 856–857. http://access.bl.uk/ark:/81055/vdc_100159756831.0x00001b